diabetic retinopathy semaglutide provides powerful protection against retinopathy, the leading cause of blindness in working-age adults, Greek study suggests Key Facts GPs Should Know

Regular monitoring and lifestyle guidance ensure that each patient receives safe, supportive care throughout their treatment journey

Cholecystitis was reported by 0.6% of Wegovy patients and 0.2% of placebo patients

With significant caloric restriction, studies show the body may reduce conversion of thyroid hormone T4 to the more active T3 form and alter sympathetic nervous system activity, both of which can influence heat production

However, concerns have been raised over the safety of pregnant women using GLP-1 receptor agonists

Side Effects Monitoring (Practical OPD Protocol) A

Learn more by visiting semaglutide.com